Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of prednisolone with amoxicillin/clavulanate is used in various clinical contexts. This combination therapy has been studied for treating conditions such as acute sinusitis, chronic obstructive pulmonary disease (COPD) exacerbations, severe alcohol-related hepatitis, and hidradenitis suppurativa flares. Efficacy and Clinical Use In the treatment of acute sinusitis, the combination of amoxicillin-clavulanate with corticosteroids has shown to resolve symptoms more quickly than antibiotics alone. For COPD exacerbations of moderate severity, however, one study found no significant benefit in adding amoxicillin-clavulanate to prednisolone treatment. For hidradenitis suppurativa flares, a prospective observational study used a regimen of oral prednisone (a 40 mg taper decreasing by 10 mg every 3 days) combined with amoxicillin/clavulanate (875/125 mg twice daily for 10 days), which was found to ameliorate flares and associated pain. In patients with severe alcohol-related hepatitis, amoxicillin-clavulanate combined with prednisolone was not associated with improved 60-day survival compared to prednisolone with placebo, though infection rates were significantly lower in the combination therapy group (29.7% vs 41.5%). Safety and Interactions No direct drug interactions have been found between amoxicillin/clavulanate and prednisone/prednisolone. Generally, these medications can be taken together safely, especially for short-term use. However, there are some considerations when combining these medications: 1. Corticosteroids can suppress the immune response and should not be taken longer than prescribed for acute bacterial infections. 2. The combination may potentially impact the immune system, particularly with long-term use. 3. Patients should always consult healthcare providers about their health history before taking both medications together. Dosing Information Amoxicillin/clavulanate is commonly administered in the following dosages: - 875/125 mg twice daily (every 12 hours) - 500/125 mg three times daily (every 8 hours) When combined with prednisolone/prednisone for specific conditions: - For hidradenitis suppurativa flares: amoxicillin/clavulanate 875/125 mg twice daily for 10 days with prednisone 40 mg taper (decreasing by 10 mg every 3 days) - For COPD exacerbations: amoxicillin/clavulanate 500/125 mg three times daily for 7 days with prednisolone 30 mg/day for 7 days This combination therapy represents a practical approach for managing acute exacerbations of various conditions, though its efficacy varies depending on the specific condition being treated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prednisolone, Amoxicillin, and Clavulanate combination.